Grünenthal has taken another step in expanding the global reach of its pain-management portfolio, signing an agreement that grants Australia-based Clinect exclusive rights to commercialise the company’s Qutenza patch in the local market. …
Grünenthal partners with Clinect to bring non-opioid pain patch to Australia
February 24, 2026 Latest NewsBioPharma
Latest Video
Georgia Forrest
New Stories
-
Scientists identify highly specific targets that could transform multiple myeloma treatment
March 15, 2026 - - Australian Biotech -
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News